8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-

8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-

Cat. No.: PI1206524857

8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-
Product Details Other Identifiers Computed Properties
CAS 1206524-85-7
Purity 99%
Molecular Formula C29H38N4O7
Molecular Weight 554.63
Molar Refractivity 154.59
Pubchem ID 46930991
InChI Key IVROMYPOGKZNLP-FDOFPDFBSA-N
MDL Number MFCD31561044
Hydrogen Bond Donor Count 2.0
Hydrogen Bond Acceptor Count 9.0
Rotatable Bond Count 3
Topological Polar Surface Area 140.18 Ų
Heavy Atom Count 40
Aromatic Heavy Atoms Number 10
Fraction Csp3 0.62
Log Po/w (iLOGP) 3.97
Log Po/w (XLOGP3) 4.64
Log Po/w (WLOGP) 2.96
Log Po/w (MLOGP) 1.79
Log Po/w (SILICOS-IT) 1.95
Consensus Log Po/w 3.06
GI Absorption Low
BBB Permeant No
P-gp Substrate Yes
CYP1A2Inhibitor No
CYP2C19Inhibitor No
CYP2C9Inhibitor No
CYP2D6Inhibitor No
CYP3A4Inhibitor No
Log Kp (Skin Permeation) -6.39 cm/s
Lipinski 2.0
Ghose None
Veber 1.0
Egan 1.0
Muegge 0.0
Bioavailability Score 0.56
PAINS 0.0 alert
Brenk 0.0 alert
Leadlikeness 2.0
Synthetic Accessibility 6.9

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2